UB Study Investigates Chlorhexidine’s Effect on Diabetes-Related Inflammation
A recent study conducted by researchers at the University at Buffalo (UB) in New York explored the connection between periodontal diseases and diabetes, discovering an effective strategy to reduce inflammation among patients with diabetes. Individuals with periodontal diseases have a 20% to 30% higher likelihood of developing diabetes, while those with diabetes are 1.5 times more prone to periodontal diseases. The study investigated the use of chlorhexidine mouthrinse to reduce periodontal inflammation in patients with type 2 diabetes, revealing significant improvement with chlorhexidine use. The study was conducted by Patricia Diaz, DDS, PhD, a professor at UB’s School of Dental Medicine and director of UB’s Microbiome Center, who was recently appointed to the Sunstar Robert J. Genco Endowment Chair, a 5-year position supporting UB researchers who facilitate medical and dental collaboration in oral biology and periodontal medicine. The study was published in JDR Clinical and Translational Research. Click here to read more.